<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3098">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01815801</url>
  </required_header>
  <id_info>
    <org_study_id>H-1301-066-459</org_study_id>
    <nct_id>NCT01815801</nct_id>
  </id_info>
  <brief_title>Effect of Mechanical Ventilation on the Incidence of Pneumothorax After Subclavian Vein Catheterization</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <authority>South Korea: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether mechanical ventilation influences the
      incidence of pneumothorax after subclavian venous catheterization.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">March 2016</completion_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>incidence of pneumothorax</measure>
    <time_frame>an expected average of one day after surgery</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Postoperative chest X-ray will be taken to check for the occurence of pneumothorax.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>catheterization success rate</measure>
    <time_frame>an expected average of one day after surgery</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">334</enrollment>
  <condition>Subclavian Vein Catheterization</condition>
  <arm_group>
    <arm_group_label>Ventilated group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lungs were mechanically ventilated during subclavian vein catheterization.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Lungs were not mechanically ventilated during subclavian vein catheterization.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Lungs were not mechanically ventilated during subclavian vein catheterization</intervention_name>
    <description>Control group</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Lungs were mechanically ventilated during subclavian vein catheterization</intervention_name>
    <description>Ventilated group</description>
    <arm_group_label>Ventilated group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adult patients undergoing neurosurgery that requires the placement of subclavian
             venous catheterization

        Exclusion Criteria:

          -  infection over the puncture site

          -  history of prior clavicular fracture

          -  anatomical anomaly of subclavian vein

          -  Pneumothorax
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jae-Hyon Bahk, MD PhD</last_name>
    <phone>82-2-2072-2818</phone>
    <email>bahkjh@snu.ac.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jae-Hyon Bahk, MD PhD</last_name>
      <phone>82-2-2072-2818</phone>
      <email>bahkjh@snu.ac.kr</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2013</verification_date>
  <lastchanged_date>March 20, 2013</lastchanged_date>
  <firstreceived_date>March 19, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Jae-Hyon Bahk, MD, PhD</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
